Joshua Hexter

Companies

• Oramed PharmaceuticalsChief operating officer Apr 16, 2013 to now¹
• Oramed PharmaceuticalsChf. Op. & Bus. Officer Sep 16, 2019 to Sep 16, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Oramed Pharmaceuticals ORMP1,358,130 shares³$5.5M at $4.08Sep 24, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 24, 2026Granted 209,291 shares of Oramed Pharmaceuticals³
• Sep 24, 2026Granted 75,455 shares of Oramed Pharmaceuticals³
• Jul 2, 2026Exercised options 50,000 shares at $3.69 of Oramed Pharmaceuticals⁴
• Jul 1, 2026Sold 137,000 shares at $4.46 of Oramed Pharmaceuticals⁴
• Mar 17, 2026Granted 95,889 shares of Oramed Pharmaceuticals⁵
• Jan 22, 2026Exercised options 19,000 shares of Oramed Pharmaceuticals⁶
• Dec 31, 2025Granted 115,000 shares of Oramed Pharmaceuticals⁷
• Dec 31, 2025Granted 97,328 shares of Oramed Pharmaceuticals⁷
• Feb 11, 2025Granted 33,334 shares of Oramed Pharmaceuticals⁸
• Feb 11, 2025Granted 48,500 shares of Oramed Pharmaceuticals⁸
• Feb 11, 2025Granted 45,000 shares of Oramed Pharmaceuticals⁸
• Jan 2, 2025Granted 194,500 shares of Oramed Pharmaceuticals⁹
• Nov 7, 2024Granted 30,000 shares of Oramed Pharmaceuticals¹⁰
• Jan 4, 2024Granted 180,500 shares of Oramed Pharmaceuticals¹¹
• May 26, 2023Granted 27,000 shares of Oramed Pharmaceuticals¹²
• Apr 17, 2023Granted 108,000 shares of Oramed Pharmaceuticals¹³
• Jul 28, 2022Granted 42,000 shares of Oramed Pharmaceuticals¹⁴
• Jan 3, 2022Granted 21,000 shares of Oramed Pharmaceuticals¹⁵